tm
Seeing Is Believing
tm
Seeing Is Believing
CHRS is currently covered by 7 analysts with an average potential upside of $10.43 (85.03%) backed by displayed 40 price targets and 53 ratings.
Analysts average stock forecasts to be materialized ratio is 8.75% with an average time for these price targets to be met of 97.8 days.
Highest price target for CHRS is 14, Lowest price target is 2, average price target is 8.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 08-Nov-2023. First documented stock forecast 27-Jul-2016.
Currently, out of the existing stock ratings of CHRS - 11 which are a Buy (61.11%), 7 which are a Hold (38.89%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
22
21 days ago
3/8 (37.5%)
$8.2 (41.13%)
181
Buy
7
$4.89 (231.75%)
13
1 months 6 days ago
0/10 (0%)
$8.72 (70.43%)
Buy
20
$16.26 (434.76%)
20
2 months 3 days ago
0/16 (0%)
$15.25 (204.76%)
Buy
7
$4.89 (231.75%)
11
3 months 22 days ago
0/2 (0%)
$3.28 (55.39%)
Hold
7
$4.89 (231.75%)
10
3 months 26 days ago
1/3 (33.33%)
$2.1 (27.76%)
194
What is CHRS (Coherus BioSciences) average time for price targets to be met?
Which analyst has the current highest performing score on CHRS (Coherus BioSciences) with a proven track record?
Which analyst has the most public recommendations on CHRS (Coherus BioSciences)?
Which analyst is the currently most bullish on CHRS (Coherus BioSciences)?
Which analyst is the currently most reserved on CHRS (Coherus BioSciences)?
